Search results
Results From The WOW.Com Content Network
Croup is usually treated with a single dose of steroids by mouth. [2] [7] In more severe cases inhaled epinephrine may also be used. [2] [8] Hospitalization is required in one to five percent of cases. [9] Croup is a relatively common condition that affects about 15% of children at some point. [4]
It is occasionally confused with croup. If it is inflamed, a condition known as tracheitis can occur. In this condition there can be inflammation of the linings of the trachea. A condition called tracheo-bronchitis can be caused, when the mucous membrane of the trachea and bronchi swell.
HPIV-1 and HPIV-2 have been demonstrated to be the principal causative agent behind croup (laryngotracheobronchitis), which is a viral disease of the upper airway and is mainly problematic in children aged 6–48 months of age.
Croup (Laryngotracheobronchitis) is a viral infection of the vocal cords typically lasting five to six days. The main symptom is a barking cough and low-grade fever. On an X-ray, croup can be recognized by the "steeple sign", which is a narrowing of the trachea. It most commonly occurs in winter months in children between the ages of 3 months ...
[1] [2] The presence of the steeple sign supports a diagnosis of croup, usually caused by paramyxoviruses. [3] It can also be defined as the replacement of the usual squared-shoulder appearance of the subglottic area by cone-shaped narrowing just distal to the vocal cords. This is called the steeple or pencil-point sign.
The primary symptom is a cough with sputum that may be purulent.The illness may also cause shortness of breath or wheezing. Upper respiratory tract infections (URTIs) often precede acute bronchitis, with overlapping symptoms including headache, nasal congestion, and sore throat.
These resulted in 2.74 million deaths down from 3.4 million deaths in 1990. [5] [2] This was 4.8% of all deaths in 2013. [5] The World Health Organization has reported that, in 2021, "Lower respiratory infections remained the world’s most deadly communicable disease other than COVID-19, ranked as the fifth leading cause of death." However ...
The use of vitamin C in the inhibition and treatment of upper respiratory infections has been suggested since the initial isolation of vitamin C in the 1930s. Some evidence exists to indicate that it could be justified in persons exposed to brief periods of severe physical exercise and/or cold environments. [ 29 ]